I

ImmVira

19 employees

Immvira’s scientific objectives are based on numerous experimental designs of oHSV and outcomes of clinical trials.

Basic info

Industry

biotechnology research

Sectors

Clinical Trials

Date founded

2015

Funding rounds raised

Total raised

$58M

from 14 investors over 14 rounds

I

ImmVira raised undisclosed on October 26, 2022

Investors: 乾道锦鲤管理顾问(北京)有限公司 and China Merchants China Investment Management Limited

I

ImmVira raised $8M on September 29, 2022

Investors: China Merchants Capital

I

ImmVira raised undisclosed on December 31, 2020

Investors: Octagon Capital, 博儒资本, China Merchants Capital, 澜亭资本, Hillhouse Capital Management and OrbiMed Advisors

I

ImmVira raised $58M on June 15, 2020

Investors: 华盖资本有限责任公司 and Cowin Venture Capital

I

ImmVira raised $15M on January 31, 2019

Investors: Med-Fine Capital, 深圳前海勤智国际资本管理有限公司 and 上海涌铧投资管理有限公司

FAQ